Diamyd Medical AB (publ) (FRA:DMN)

Diamyd Medical AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 9, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Capitalization	162	140	144	71	105	237
Market Cap Growth	8.26%	-2.83%	103.88%	-32.46%	-55.71%	-10.78%
Enterprise Value	136	111	130	64	87	217
Last Close Price	1.06	0.99	1.28	0.79	1.32	3.00
PE Ratio	-	-	-	-	-	40.17
PS Ratio	13781.93	11951.90	12595.78	1538.11	2470.47	9533.21
PB Ratio	6.40	5.55	11.22	4.96	5.23	12.74
P/TBV Ratio	6.40	5.55	11.22	4.96	5.23	12.75
EV/Sales Ratio	-	9496.04	11346.68	1396.51	2045.78	8765.65
EV/FCF Ratio	-8.37	-	-	-	-	-
Asset Turnover	0	0	0.00	0.00	0.00	0.00
Quick Ratio	10.25	10.25	3.41	6.66	7.59	12.37
Current Ratio	10.64	10.64	3.98	7.09	8.10	14.29
Return on Equity (ROE)	-79.72%	-79.72%	-96.32%	-60.49%	-51.29%	45.88%
Return on Assets (ROA)	-40.21%	-40.21%	-43.54%	-32.74%	-32.80%	-36.95%
Return on Capital (ROIC)	-53.78%	-53.78%	-58.38%	-37.73%	-35.59%	-41.10%
Return on Capital Employed (ROCE)	-56.40%	-56.40%	-83.20%	-62.30%	-53.40%	-45.30%
Earnings Yield	-9.48%	-10.93%	-9.27%	-13.82%	-9.23%	2.49%
FCF Yield	-10.03%	-11.57%	-8.38%	-14.57%	-11.40%	-4.71%
Buyback Yield / Dilution	-18.81%	-18.81%	-20.98%	-2.29%	-9.65%	-0.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.